Digest Network Come funziona
Network
/
Società
Lu
Non verificato

Luxa Biotechnology LLC

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaIndustriaSalute

4 comunicati stampa

Guarda tutti i comunicati
29/04/2025
Eventi
Industria
Salute
Biologia
Sanità
Medicina - Varie
Farmaceutica
Ottica
Biotecnologia
Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting
Fonte
Luxa Biotechnology LLC
Emittente
Business Wire
1.00
0
06/03/2025
Eventi
Industria
Scienza
Igiene alimentare
Medicina - Varie
Biologia
Biotecnologia
Salute
Farmaceutica
Ottica
Luxa Biotechnology Presents Clinical Data from First-in-Human Retinal Pigment Epithelium Cell Therapy Trial for Dry Age-Related Macular Degeneration at the 77th Annual Wills Eye Conference
Fonte
Luxa Biotechnology LLC
Emittente
Business Wire
1.00
0
18/02/2025
Eventi
Industria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Ottica
Luxa Biotechnology Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to RPESC-RPE-4W Transplantation for the Treatment of Dry Age-Related Macular Degeneration
Fonte
Luxa Biotechnology LLC
Emittente
Business Wire
1.00
0
01/10/2024
Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Fonte
Luxa Biotechnology LLC
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0